Literature DB >> 20137985

Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes.

Alexandre Boissonnas1, Alix Scholer-Dahirel, Virginie Simon-Blancal, Luigia Pace, Fabien Valet, Adrien Kissenpfennig, Tim Sparwasser, Bernard Malissen, Luc Fetler, Sebastian Amigorena.   

Abstract

Regulatory T (Treg) cells limit the onset of effective antitumor immunity, through yet-ill-defined mechanisms. We showed the rejection of established ovalbumin (OVA)-expressing MCA101 tumors required both the adoptive transfer of OVA-specific CD8(+) T cell receptor transgenic T cells (OTI) and the neutralization of Foxp3(+) T cells. In tumor-draining lymph nodes, Foxp3(+) T cell neutralization induced a marked arrest in the migration of OTI T cells, increased numbers of dendritic cells (DCs), and enhanced OTI T cell priming. Using an in vitro cytotoxic assay and two-photon live microscopy after adoptive transfer of DCs, we demonstrated that Foxp3(+) T cells induced the death of DCs in tumor-draining lymph nodes, but not in the absence of tumor. DC death correlated with Foxp3(+) T cell-DC contacts, and it was tumor-antigen and perforin dependent. We conclude that Foxp3(+) T cell-dependent DC death in tumor-draining lymph nodes limits the onset of CD8(+) T cell responses. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20137985     DOI: 10.1016/j.immuni.2009.11.015

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  78 in total

1.  Critical role for perforin and Fas-dependent killing of dendritic cells in the control of inflammation.

Authors:  Min Chen; Kumar Felix; Jin Wang
Journal:  Blood       Date:  2011-10-31       Impact factor: 22.113

2.  Illuminating emergent activity in the immune system by real-time imaging.

Authors:  Matthew F Krummel
Journal:  Nat Immunol       Date:  2010-07       Impact factor: 25.606

3.  Scaffold protein Disc large homolog 1 is required for T-cell receptor-induced activation of regulatory T-cell function.

Authors:  Alexandra Zanin-Zhorov; Jiqiang Lin; Jose Scher; Sudha Kumari; David Blair; Keli L Hippen; Bruce R Blazar; Steven B Abramson; Juan J Lafaille; Michael L Dustin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

Review 4.  Regulatory T cell migration during an immune response.

Authors:  Yaozhong Ding; Jiangnan Xu; Jonathan S Bromberg
Journal:  Trends Immunol       Date:  2012-02-02       Impact factor: 16.687

Review 5.  CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity.

Authors:  G Elizabeth Pluhar; Christopher A Pennell; Michael R Olin
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

6.  Perforin is a critical physiologic regulator of T-cell activation.

Authors:  Jennifer E Lykens; Catherine E Terrell; Erin E Zoller; Kimberly Risma; Michael B Jordan
Journal:  Blood       Date:  2011-05-23       Impact factor: 22.113

7.  Cancer immunotherapy meets biomaterials.

Authors:  Jeffrey S Weber; James J Mulé
Journal:  Nat Biotechnol       Date:  2015-01       Impact factor: 54.908

8.  Polyclonal Treg cells modulate T effector cell trafficking.

Authors:  Todd S Davidson; Ethan M Shevach
Journal:  Eur J Immunol       Date:  2011-08-30       Impact factor: 5.532

Review 9.  Functional immunoimaging: the revolution continues.

Authors:  Philippe Bousso; Hélène D Moreau
Journal:  Nat Rev Immunol       Date:  2012-12       Impact factor: 53.106

10.  Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model.

Authors:  John R Ohlfest; Brian M Andersen; Adam J Litterman; Junzhe Xia; Christopher A Pennell; Lauryn E Swier; Andres M Salazar; Michael R Olin
Journal:  J Immunol       Date:  2012-12-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.